Byondis jobs and careers
NIJMEGEN, Netherlands
About Byondis
With a passion for outsmarting relentless cancers and autoimmune diseases, Byondis takes precision medicines to the next level. We are driven by one goal: providing novel treatments with high efficacy and low systemic toxicity for patients with high unmet medical needs. Many companies work in the areas of unmet need. What differentiates Byondis is its focus on producing a broad spectrum of molecular concepts, ranging from small molecule chemistries to complex protein structures. We engineer smaller and larger molecular functionalities that may be combined to target the right part of the body. This involves: • Next generation antibody-drug conjugates (ADCs), including proprietary linker-drug (LD) technology to generate multiple ADC candidates targeting different indications • Site-specific conjugation technology • Monoclonal antibodies (mAbs) • Highly selective, disease-targeting small molecules The success of our company fully depends on our people. To them, we aim to provide a fair, open and inspiring working environment, where there is room for ambition, entrepreneurship and new initiatives leading to new medicines that save and transform patients’ lives.
Founded in 2010 by Jacques Lemmens.
- Founded
- 2010
- Employees
- 350
- Headquarters
- NIJMEGEN
Leadership
The top of Byondis's org chart, with how many people report into each leader.
Wim Dokter
Chief Scientific Officer
57 reports
Aad van de Leur
COO
33 reports
Ronald Smulders
Senior Director Quality Assurance
17 reports
Norbert Koper
Vice President Clinical Development
4 reports
Ivo Grgic
Senior Director Business Development & Licensing
1 report
Marieke van Gent
Vice President Intellectual Property
1 report
Suzanne van Gerwen
Director Business Development
Benno Ingelse
Senior Director Bioanalysis & Protein Interaction
16 reports
Bas Kokke
Principal Scientist DSP
7 reports
Miranda van der Lee
Senior Director In Vitro Pharmacology
7 reports
Patrick Beusker
Senior Director Medicinal & Protein Chemistry
5 reports
Alyson MacInnes
Director Biomarker Discovery And Development
4 reports
Ruud Ubink
Senior Director DMPK
2 reports
Patrick Groothuis
Principal Scientist, In Vivo Pharmacology, Toxicology & DMPK
1 report
Taiwo Ajayi
Head Of Biometrics
1 report
Jobs at Byondis
No open positions right now. Explore more companies on TheJobsMap.